Ayala Pharmaceuticals Inc (ADXS)

[Simple Steve]

Exactly right Barrell. The drop below $3 was due to investors' worry that ADXS products do not work, or at least are not good enough to beat its competitors (or SOC) by a significant enough margin to ever get approved and out to market for a profit. In the end it's all about making money, and if BP doesn't think they can make money, they won't buy our drugs. The poor AXAL anal results do not help. The bottom line is that the jury is still out on ADXS's products. It's not hopeless, but ADXS has to offer up some proof before BP comes knocking, IMO.